Cargando…

Pitfalls of the S-ICD therapy: experiences from a large tertiary centre

AIM: The subcutaneous ICD (S-ICD) has evolved to a potential first option for many patients who have to be protected from sudden cardiac death. Many trials have underlined a similar performance regarding its effectiveness in relation to transvenous ICDs and have shown the expected benefits concernin...

Descripción completa

Detalles Bibliográficos
Autores principales: Willy, Kevin, Reinke, Florian, Rath, Benjamin, Ellermann, Christian, Wolfes, Julian, Bögeholz, Nils, Köbe, Julia, Eckardt, Lars, Frommeyer, Gerrit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166696/
https://www.ncbi.nlm.nih.gov/pubmed/33130912
http://dx.doi.org/10.1007/s00392-020-01767-x
_version_ 1783701549696942080
author Willy, Kevin
Reinke, Florian
Rath, Benjamin
Ellermann, Christian
Wolfes, Julian
Bögeholz, Nils
Köbe, Julia
Eckardt, Lars
Frommeyer, Gerrit
author_facet Willy, Kevin
Reinke, Florian
Rath, Benjamin
Ellermann, Christian
Wolfes, Julian
Bögeholz, Nils
Köbe, Julia
Eckardt, Lars
Frommeyer, Gerrit
author_sort Willy, Kevin
collection PubMed
description AIM: The subcutaneous ICD (S-ICD) has evolved to a potential first option for many patients who have to be protected from sudden cardiac death. Many trials have underlined a similar performance regarding its effectiveness in relation to transvenous ICDs and have shown the expected benefits concerning infective endocarditis and lead failure. However, there have also been problems due to the peculiarities of the device, such as oversensing and myopotentials. In this study, we present patients from a large tertiary centre suffering from complications with an S-ICD and propose possible solutions. METHODS AND RESULTS: All S-ICD patients who experienced complications related to the device (n = 40) of our large-scale single-centre S-ICD registry (n = 351 patients) were included in this study. Baseline characteristics, complications occurring and solutions to these problems were documented over a mean follow-up of 50 months. In most cases (n = 23), patients suffered from oversensing (18 cases with T wave or P wave oversensing, 5 due to myopotentials). Re-programming successfully prevented further oversensing episode in 13/23 patients. In 9 patients, generator or lead-related complications, mostly due to infectious reasons (5/9), occurred. Further problems consisted of ineffective shocks in one patient and need for antibradycardia stimulation in 2 patients and indication for CRT in 2 other patients. In total, the S-ICD had to be extracted in 10 patients. 7 of them received a tv-ICD subsequently, 3 patients refused re-implantation of any ICD. One other patient kept the ICD but had antitachycardic therapy deactivated due to inappropriate shocks for myopotential oversensing. CONCLUSION: The S-ICD is a valuable option for many patients for the prevention of sudden cardiac death. Nonetheless, certain problems are immanent to the S-ICD (limited re-programming options, size of the generator) and should be addressed in future generations of the S-ICD. GRAPHIC ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-8166696
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-81666962021-06-03 Pitfalls of the S-ICD therapy: experiences from a large tertiary centre Willy, Kevin Reinke, Florian Rath, Benjamin Ellermann, Christian Wolfes, Julian Bögeholz, Nils Köbe, Julia Eckardt, Lars Frommeyer, Gerrit Clin Res Cardiol Original Paper AIM: The subcutaneous ICD (S-ICD) has evolved to a potential first option for many patients who have to be protected from sudden cardiac death. Many trials have underlined a similar performance regarding its effectiveness in relation to transvenous ICDs and have shown the expected benefits concerning infective endocarditis and lead failure. However, there have also been problems due to the peculiarities of the device, such as oversensing and myopotentials. In this study, we present patients from a large tertiary centre suffering from complications with an S-ICD and propose possible solutions. METHODS AND RESULTS: All S-ICD patients who experienced complications related to the device (n = 40) of our large-scale single-centre S-ICD registry (n = 351 patients) were included in this study. Baseline characteristics, complications occurring and solutions to these problems were documented over a mean follow-up of 50 months. In most cases (n = 23), patients suffered from oversensing (18 cases with T wave or P wave oversensing, 5 due to myopotentials). Re-programming successfully prevented further oversensing episode in 13/23 patients. In 9 patients, generator or lead-related complications, mostly due to infectious reasons (5/9), occurred. Further problems consisted of ineffective shocks in one patient and need for antibradycardia stimulation in 2 patients and indication for CRT in 2 other patients. In total, the S-ICD had to be extracted in 10 patients. 7 of them received a tv-ICD subsequently, 3 patients refused re-implantation of any ICD. One other patient kept the ICD but had antitachycardic therapy deactivated due to inappropriate shocks for myopotential oversensing. CONCLUSION: The S-ICD is a valuable option for many patients for the prevention of sudden cardiac death. Nonetheless, certain problems are immanent to the S-ICD (limited re-programming options, size of the generator) and should be addressed in future generations of the S-ICD. GRAPHIC ABSTRACT: [Image: see text] Springer Berlin Heidelberg 2020-11-01 2021 /pmc/articles/PMC8166696/ /pubmed/33130912 http://dx.doi.org/10.1007/s00392-020-01767-x Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Paper
Willy, Kevin
Reinke, Florian
Rath, Benjamin
Ellermann, Christian
Wolfes, Julian
Bögeholz, Nils
Köbe, Julia
Eckardt, Lars
Frommeyer, Gerrit
Pitfalls of the S-ICD therapy: experiences from a large tertiary centre
title Pitfalls of the S-ICD therapy: experiences from a large tertiary centre
title_full Pitfalls of the S-ICD therapy: experiences from a large tertiary centre
title_fullStr Pitfalls of the S-ICD therapy: experiences from a large tertiary centre
title_full_unstemmed Pitfalls of the S-ICD therapy: experiences from a large tertiary centre
title_short Pitfalls of the S-ICD therapy: experiences from a large tertiary centre
title_sort pitfalls of the s-icd therapy: experiences from a large tertiary centre
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166696/
https://www.ncbi.nlm.nih.gov/pubmed/33130912
http://dx.doi.org/10.1007/s00392-020-01767-x
work_keys_str_mv AT willykevin pitfallsofthesicdtherapyexperiencesfromalargetertiarycentre
AT reinkeflorian pitfallsofthesicdtherapyexperiencesfromalargetertiarycentre
AT rathbenjamin pitfallsofthesicdtherapyexperiencesfromalargetertiarycentre
AT ellermannchristian pitfallsofthesicdtherapyexperiencesfromalargetertiarycentre
AT wolfesjulian pitfallsofthesicdtherapyexperiencesfromalargetertiarycentre
AT bogeholznils pitfallsofthesicdtherapyexperiencesfromalargetertiarycentre
AT kobejulia pitfallsofthesicdtherapyexperiencesfromalargetertiarycentre
AT eckardtlars pitfallsofthesicdtherapyexperiencesfromalargetertiarycentre
AT frommeyergerrit pitfallsofthesicdtherapyexperiencesfromalargetertiarycentre